Results 11 to 20 of about 13,683 (246)

How to calculate the ASDAS based on C-reactive protein without individual questions from the BASDAI: the BASDAI-based ASDAS formula [PDF]

Rheumatology, 2019
OBJECTIVES To develop a new equation to calculate the Ankylosing Spondylitis Disease Activity Score based on CRP (ASDAS-CRP) using only the BASDAI total score and CRP.
I. C. Aranda-Valera, Juan Luis Garrido-Castro, Lourdes Ladehesa-Pineda, Janitzia Vázquez‐Mellado, Pedro Zarco, Xavier Juanola, C. González-Navas, Pilar Font, Carmen Castro   +8 more
semanticscholar   +6 more sources

How to deal with missing items in BASDAI and BASFI [PDF]

Rheumatology, 2013
SIR, The BASDAI and BASFI are frequently used for the assessment of disease activity and function, respectively, in patients with axial SpA [1, 2]. However, the calculation of BASDAI and BASFI scores is only defined for cases when all the questions (6 ...
Sofía Ramiro, Astrid van Tubergen, D. van der Heijde, Filip Van den Bosch, M. Dougados, Robert Landewé   +5 more
semanticscholar   +5 more sources

BASDAI cut-off values corresponding to ASDAS cut-off values [PDF]

Rheumatology, 2021
OBJECTIVE To determine cut-off values of Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) that can discriminate the four disease activity states (inactive disease, moderate disease activity, high disease activity, and very high disease ...
Oh Chan Kwon, Min‐Chan Park
semanticscholar   +6 more sources

Selecting patients with ankylosing spondylitis for TNF inhibitor therapy: comparison of ASDAS and BASDAI eligibility criteria [PDF]

Rheumatology, 2012
OBJECTIVE To compare Ankylosing Spondylitis Disease Activity Score (ASDAS) ≥2.1 with BASDAI >4 as an eligibility criterion for initiation of TNF inhibitor (TNFi) treatment in AS, and to investigate if ASDAS performs satisfactorily in patients without ...
K. M. Fagerli, E. Lie, Désirée van der Heijde, Marte Schrumpf Heiberg, C. Kaufmann, E Rødevand, Kim Lyngby Mikkelsen, S. Kalstad, T. K. Kvien   +8 more
semanticscholar   +5 more sources

Multicenter validation of the value of BASFI and BASDAI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patients [PDF]

Rheumatology International, 2009
The objectives of this study were to evaluate the reliability of Bath ankylosing spondylitis functional index (BASFI) and Bath ankylosing spondylitis disease activity index (BASDAI) in Chinese ankylosing spondylitis (AS) and undifferentiated ...
Zhiming Lin, Jieruo Gu, Peigen He, Jiesheng Gao, Xiaoxia Zuo, Zhizhong Ye, Fengmin Shao, Zhan Feng, Jinying Lin, Li Li, Yanlin Wei, Manlong Xu, Zetao Liao, Qu Lin   +13 more
semanticscholar   +5 more sources

Spectrum of ankylosing spondylitis in Portugal. Development of BASDAI, BASFI, BASMI and mSASSS reference centile charts [PDF]

Clinical Rheumatology, 2011
The availability of population-specific normative data regarding disease severity measures is essential for patient assessment. The goals of the current study were to characterize the pattern of ankylosing spondylitis (AS) in Portuguese patients and to develop reference centile charts for BASDAI, BASFI, BASMI and mSASSS, the most widely used assessment
Fernando Pimentel‐Santos, Ana Filipa Mourão, Célia Ribeiro, José Costa, Helena Santos, Anabela Barcelos, Patrícia Pinto, Fátima Godinho, Margarida Cruz, Elsa Vieira‐Sousa, Rui André Santos, S Rabiais, J Félix, João Eurico Fonseca, Henrique Guedes‐Pinto, Matthew A. Brown, Jaime Branco   +16 more
semanticscholar   +9 more sources

Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor blockers in ankylosing spondylitis [PDF]

Annals of the Rheumatic Diseases, 2004
TNFalpha blockers have been shown to be highly efficacious in patients with active ankylosing spondylitis (AS).To identify parameters predicting the clinical response to TNF blockers in AS.Patients with active AS participated in two placebo controlled, randomised trials conducted in Germany with infliximab (n = 69) and etanercept (n = 30), respectively.
Martín Rudwaleit
semanticscholar   +6 more sources

BASDAI versus ASDAS in evaluating axial involvement in patients with psoriatic arthritis: a pooled analysis of two phase 3 studies [PDF]

Rheumatology Advances in Practice
Objective In the absence of axial psoriatic arthritis (axPsA)-specific tools, the BASDAI and Ankylosing Spondylitis Disease Activity Score (ASDAS) are used to assess axial symptoms in patients with PsA.
Xenofon Baraliakos, Dafna D. Gladman, Soumya D. Chakravarty, Cinty Gong, M. Shawi, Emmanouil Rampakakis, Mitsumasa Kishimoto, Enrique R. Soriano, Philip J. Mease   +8 more
openalex   +2 more sources

BASDAI and ASDAS disease states in relationship to ASAS40 response: post hoc analysis of ixekizumab in radiographic axial spondyloarthritis. [PDF]

Rheumatol Adv Pract
Abstract Objectives To explore the relationship between Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Axial Spondyloarthritis Disease Activity Score (ASDAS) used in clinical practice and the Assessment of SpondyloArthritis international Society 40% (ASAS40) response, the primary ...
Rudwaleit M, Navarro-Compán V, Russ H, Panni T, Filippi E, Nassab MH, Liu-Leage S, Goëb V, Ciccia F, Dudler J.   +9 more
europepmc   +5 more sources

Intra-rater reliability of the bath ankylosing spondylitis disease activity index (BASDAI) and the bath ankylosing spondylitis functional index (BASFI) in children with spondyloarthritis [PDF]

Pediatric Rheumatology Online Journal, 2012
Purpose Juvenile spondyloarthritis (JSpA), referred to as enthesitisrelated arthritis (ERA) sub-type under the International League of Associations for Rheumatology (ILAR) classification of juvenile idiopathic arthritis (JIA), is characterized by ...
Michelle Batthish, Alisa Rachlis, Bertha Wong, Samantha Stevens, Michelle A. Anderson, Brian M. Feldman, Ronald M. Laxer, Jo-Anne Marcuz, Margaret Reaume, Lynn Spiegel, Kristi Whitney-Mahoney, Shirley M. L. Tse   +11 more
openalex   +2 more sources